MEDI-528, now recognized as enokiizumab , represents a novel medication targeting the IGF-1R , a key protein implicated in several skin conditions . Early investigation data suggest significant efficacy https://qasimdsfh665568.wikipresses.com/7451013/enokizumab_a_deep_dive_into_medi_528_and_its_potential